|ORIGINAL RESEARCH ARTICLE
|Year : 2018 | Volume
| Issue : 1 | Page : 14-23
In vitro characterization of statistically optimized quetiapine-loaded self-nanoemulsified systems with quality by design
Jyothshna Devi Katamreddy1, Prasanna Raju Yalavarthi2, D Subba Rao3, S P Surya Teja4, Sowjanya Battu5
1 Faculty of Pharmaceutical Sciences, JNTUA University, Tirupati, Andhra Pradesh, India
2 Division of Pharmaceutics, Sri Padmavathi School of Pharmacy, Tirupati, Andhra Pradesh, India
3 Department of Chemical Engineering, JNTUA College of Engineering, Anantapur, India
4 Department of Pharmaceutics, SRM University, Chennai, Tamil Nadu, India
5 Department of Pharmaceutics, CMR College of Pharmacy, Hyderabad, Telangana, India
|Date of Web Publication||11-Jul-2018|
Ms. Jyothshna Devi Katamreddy
Faculty of Pharmaceutical Sciences, JNTUA University, Anantapur
Source of Support: None, Conflict of Interest: None
Objective: To optimize and characterize quetiapine (QP)-loaded self-nanoemulsified drug delivery systems (SNEDDS) by 3-factorial 3-level Box–Behnken design (BBD) to improve the dissolution.
Methods: Amounts of olive oil (X1), tween 80 (X2), and PEG 400 (X3) as independent factors, whereas % limpidity (Y1), self-emulsification time (SET) (Y2), and drug released at 15 min (T15) (Y3) as responses were employed in BBD. Three-dimensional response surface plots were run to understand the main interaction and quadratic effects of independent variables. Preliminary screening was carried out by equilibrium solubility and emulsification efficiency studies. Nanoemulsification region was recognized by pseudoternary plot.
Results: Mean droplet size of optimized nanodispersion was 89.68 nm, electrokinetic potential was −27.2 mV and polydispersity index <1 and represented 94% of limpidity, 69 s of SET, and 93.4% of T15. Software-generated model graphs (predicted versus actual and residual versus predicted) for all three responses were produced without outliers and thus indicated the adequacy of selected statistical model.
Conclusion: This study explained the effectiveness of BBD in insights of formulation variables and quality of QP-loaded nanoemulsified systems so as to enhance dissolution. As a result, BBD was a well-suitable experimental design in predicting the responses of QP-loaded liquid SNEDDS.
Keywords: Independent-variables, interaction-effect, limpidity, model-adequacy, response surface plot, self-emulsification time
|How to cite this article:|
Katamreddy JD, Yalavarthi PR, Subba Rao D, Teja S P, Battu S. In vitro characterization of statistically optimized quetiapine-loaded self-nanoemulsified systems with quality by design. Int J Pharma Investig 2018;8:14-23
|How to cite this URL:|
Katamreddy JD, Yalavarthi PR, Subba Rao D, Teja S P, Battu S. In vitro characterization of statistically optimized quetiapine-loaded self-nanoemulsified systems with quality by design. Int J Pharma Investig [serial online] 2018 [cited 2019 Jan 24];8:14-23. Available from: http://www.jpionline.org/text.asp?2018/8/1/14/236384
| Introduction|| |
Systemic drug delivery in schizophrenia is a major confront due to the presence of hindrances like, blood–brain barrier and P-glycoprotein, which forbid the entry of drugs into the brain. Colloidal drug transporters resembling micelles, emulsions, liposomes, and nanoparticles have been largely accounted for brain drug delivery owing to the simple and easy scale-up methods of preparation. Most of the hydrophobic antipsychotic moieties were prepared as micro and nanoemulsions to overcome the intrinsic demerits such as poor solubility, precipitation, degradation, and first-pass metabolism.
Since the approval by Food and Drug Administration in 2008, quetiapine (QP) a dibenzothiazepine antipsychotic has been shown its promise in the monotherapy and maintenance of acute depressive and acute manic or mixed episodes of bipolar disorder. Frequently, lower doses of QP are also employed as an add-on medication in psychosis patients. Significant side effects of QP such as weight gain, medication-induced diabetes, and extrapyramidal symptoms are reported to be at sensible levels over other antipsychotics. Probably, these advantages have an account for 45% of QP use within the category of atypical drug moieties such as aripiprazole, ziprasidone, olanzapine, and risperidone. However, QP belongs to Biopharmaceutical Classification System (BCS) Class II category shows extremely poor bioavailability (9%) with 6 h of half-life and 2.8 of log P value. The above solubility-based issues were addressed by cyclodextrin inclusion complexes, solid dispersions, nanoparticles, solid lipid nanoparticles (SLN's),, microemulsions, lipid-core nanocapsules, microemulsions, intranasal nanoemulsions, and in situ nasal SLN's  at various instances.
Smart oral nanosized lipid systems like self-nanoemulsifying drug delivery systems (SNEDDS) are become superior in addressing solubility based issues in the recent past. The characteristic increase in interfacial area and decrease in surface free energy of internal and external phase are the core principles involved in improving the solubility, dissolution, and imparting the thermodynamic stability in SNEDDS as explained by Noyes–Whitney and Ostwald–Freundlich equations., Moreover, prominent use of long-chain and medium-chain triglycerides as carriers in SNEDDS facilitates effective dual absorption mechanisms (portal and lymph).
Pragmatically, SNEDDS are prepared by altering the carrier ratio and envisaging pseudoternary phase diagram with extended number of trails. Of late, application of statistical experimental tool in development of drug products is often practiced to optimize the quality of novel delivery systems. Central composite designs or Box–Behnken designs (BBDs) are popular among the statistical experimental tools by utilizing response surface (RS) mechanism to evaluate the relationship between formulation factors and response variables. A second-order RS model proposed by Box and Behnken is more economical since it requires fewer design runs (in three factorial design) with good prediction variance properties. Further, each factor in the design requires only three levels which are experimentally convenient to conduct.
Considering the entire facts, the present study was focused to develop an optimized formulation of QP SNEDDS by employing an accurate, robust, and significant tool of quality by design (QbD), 3-factorial 3-level BBD, and to evaluate main and interaction effects of SNEDDS formulation variables such as amounts of olive oil (X1), tween 80 (X2) as surfactant, and PEG 400 (X3) as cosurfactant on three responses: transmittance (Y1), self-emulsification time (SET) (Y2), and percentage drug released at 15 min (Y3). Three-dimensional RS plots were also aimed to envisage the effects of X1, X2, and X3 on QP release.
| Materials|| |
QP was a generous gift of M/s Aurobindo Pharma Ltd (Hyderabad, India). Oils such as canola, gingelly, olive, rice bran, soyabean, and sunflower were purchased from the local supermarket with double-refined grade. Ethanol, glycerin, isopropyl myristate, oleic acid, PEG 400, propylene glycol, span 20, span 80, tween 20, and tween 80 were obtained from M/s. Merck Specialties Ltd., Mumbai, India. Deionised double-distilled water was used throughout the study. Methanol used in the study was of analytical grade. All other chemicals and materials used in the study were generally recognized as safe with the pharmaceutical grade.
Solubility of carriers/vehicles
Solubility of QP in various liquid vehicles such as oils, surfactants, and cosurfactants was assessed by shake flask method. An excess of QP was introduced into calibrated glass vial containing 5 ml of each vehicle. Mixtures in glass vial were sonicated for 5 min and equilibrated at 25°C ± 1.0°C in an isothermal shaker for 72 h. Then, contents of each vial were centrifuged at 3000 rpm for 15 min followed by filtering off undissolved QP through 0.45 μm nylon filter. Filtered samples were suitably diluted with methanol and drug concentration was assayed at 254 nm. Experiment was repeated for three independent observations and mean value was considered. Surfactants were selected based on their major characteristics properties such as emulsification efficiency, transparency (%), and dilution ability. Span 20, span 80, tween 20, and tween 80 were selected to screen the efficiency of emulsification with optimized oil phase. A measured quantity (10 μl) of optimized oil phase was added to 10 ml of aqueous surfactant (10%w/w) continuous stirring. The experiment was continued with increments of oil phase until mixtures turn into turbid/cloudy.,
Selection of cosurfactants (by emulsification)
Ethanol, glycerin, propylene glycol, and PEG 400 were selected to screen their efficiencies in assisting the surfactants in emulsification of oils. Similar to above, the oil phase was added to aqueous solution of cosurfactant and surfactant mixture (1:1) and repeated until turbidity appears. Percentage transparency of above systems was also computed.,
Construction of ternary phase diagram
Nanoemulsion region of preconcentrates was identified by aqueous titration method. In this method, isotropic mixtures were prepared with blends of surfactant and cosurfactant (Smix) (at 1:1, 1:2, 1:3, 2:1, and 3:1 volume ratios) and oil phase at 1:9 ratio and vice versa were titrated with double-distilled water. Data obtained on spontaneous emulsification of preconcentrates were used to develop the pseudoternary phase diagrams.
Preparation of quetiapine-loaded self-nanoemulsified drug delivery systems
Weighed quantity (50 mg) of QP was thermostatically admixed with olive oil in a glass vial. Contents of glass vial were equilibrated with Smix at predetermined ratios to obtain liquid SNEDDS. The composition of liquid SNEDDS was given in [Table 1].
|Table 1: Amount of each independent variable and observed responses of 15 formulations|
Click here to view
Box–Behnken statistical rotatable screening design was employed to evaluate the main interaction and quadratic effects of selected lipid/oil, surfactant, and cosurfactants on the performance of the formulation and subsequent optimization. Design expert software version 10.0.1 was used to produce nonlinear quadratic model in BBD. A 3-level 3-factorial design was applied and amounts of oil, surfactant, and cosurfactant were selected as factors and % limpidity, (SET in seconds) and T15% were treated as responses in all 15 formulations (runs) as given in [Table 1]. Coded and actual values of high, medium, and low levels were comprehended from the pseudoternary illustrations., The following polynomial equation (1) was used to fit the mean values of experimental data as:
where Y is the analyzed response, β0 is intercept; β1 to β9 are the regression coefficients, X1, X2, and X3 are the independent variables, whereas E is error term. Generated model adequacy was supported by plots of predicted versus actual values and also residual versus predicted runs and were estimated accordingly. On the basis of polynomial or model equation, 3D-RS plots were aimed to examine the relationship between responses, mixture components, and numeric factors.
Evaluation of self-nanoemulsified drug delivery systems
SNEDDS were subjected to heating, cooling (4°C and 45°C), and freeze-thaw cycles (−21°C and + 25°C) for 48 h. Formulations were then centrifuged at 3500 rpm for 15 min to observe extent of phase separation, creaming, and coalescence.
Emulsification time of QP-loaded SNEDDS was recorded using USP type II dissolution apparatus. Each SNEDDS formulation was added dropwise to 500 ml of distilled water under continuous stirring (50 rpm) at 37°C. The emulsification time was sequentially graded on visual inspection [Table 1]. The study was repeated for similar observations in triplicate.
Limpidity measurement (percent transmittance)
The QP-loaded SNEDDS were reconstituted with deionized double-distilled water and the resulted nanoemulsions were examined for turbidity if any. Thereafter, its % transmittance was measured at 650 nm using UV-visible spectrophotometer against distilled water as blank. The studies were conducted after 100 times dilution of preconcentrates.
In vitro drug release
Dialysis bag method was employed to study the release of QP from SNEDDS. In this study, about 5 ml of each SNEDDS formulation was enclosed in a dialysis bag of molecular weight 12,000–14,000 g/mole and pore size of 2.4 nm. Aliquot of 5 ml samples were withdrawn at different time intervals by maintaining the sink condition. Further, the samples were filtered through a 0.22 μm membrane filter disc and assayed at 254 nm. Measurements were carried out in triplicate from three independent samples.
Identification of optimized formulation
Numerical optimization technique was adapted for optimizing the formulation variables to obtain desired responses. Further experiments were repeated in triplicate to determine the dependability of optimized conditions. Mean values of experimental data were compared against predicted values and thus percent error was determined. Data of the results were treated to assess the accuracy and suitability of the conditions employed in preparation of SNEDDS.
Evaluation of optimized formulation
Zeta potential and droplet size analysis
Zeta potential and droplet size distribution patterns of optimized QP-loaded SNEDDS were assessed using dynamic light scattering technique with Zeta sizer (HAS 3000, Horiba Scientific, Singapore). SNEDDS were placed in clear disposable cuvette of Zeta sizer and results were noted. The polydispersity index (PDI) values of SNEDDS were calculated using Dm= Mw/Mn equation, in which Mw is weight-average molar mass and Mn is number-average molar mass.
| Results|| |
Selection of carriers
Solubility parameter is obligatory since only specific combinations of excipient led to efficient nanoemulsion formation as shown in [Figure 1]. Both olive oil and isopropyl myristate had high solvent effect on QP as 3.61 and 2.57 mg/ml, respectively. Other liquid vehicles such as sunflower (0.173 mg/ml) and soyabean (0.163 mg/ml) oils had shown poor solubility. Solubility of QP was moderate in rice bran and canola oils. On the other hand, oil solubility of surfactants follows the rank order as span 80> tween 80> tween 20> span 20. Nonionic span 80 has characteristically high emulsification efficiency, transparency (97.3%), and five times flask inversions. Hence, span 80 was selected as amphiphilic carrier in the design of SNEDDS.
Selection of cosurfactants
Isotropic mixtures were produced on complete miscibility of cosurfactant with blend of olive oil and amphiphile. Maximum emulsification efficiency, high transmittance (99.43%), and 14 flask inversions were resulted with PEG 400 as shown in [Table 2] when compared to that of other short-chain alcohols.
|Table 2: Emulsification efficiency of selected surfactants and cosurfactants|
Click here to view
Ternary phase diagram
Nanoemulsification region was as broad as for the preconcentrate system with Smix at 1:2 (w/w) ratio over other preconcentrates, demonstrated as colored region in pseudoternary phase diagram [Figure 2]. Existence of nanoemulsion region was identified between 20 and 35 mg range for the coordinate of olive oil; 55–75 mg for coordinate of span 80 and between 33 and 45 mg range for PEG 400.
BBD was applied to optimize QP-loaded SNEDDS. As given in [Table 1] and [Table 3], coded formulation factors with responses such as percent limpidity, SET in seconds, and amount released after 15 min (T15 min) were prepared with three center points to predict the design's precision and capability. As 3D-RS plots given in [Figure 3]a,[Figure 3]b,[Figure 3]c,[Figure 3]d,[Figure 3]e,[Figure 3]f,[Figure 3]g,[Figure 3]h,[Figure 3]i, response Y1 was significantly influenced by content of X1 (amount of olive oil added) (at P = 0.0006), whereas Y2 was influenced by X1 (olive oil) (at P = 0.0002), X3 (PEG 400) (at P = 0.0187), quadratic terms X12 (at P = 0.0368), X22 (at P = 0.0514) and Y3 were affected by X1 (at P = 0.0112), X2 (at P = 0.0044), X3 (at P = 0.0059) and X12 (at P = 0.0249), respectively. Software-generated model graphs (predicted vs. actual and residual vs. predicted) for all three responses were produced without outliers and thus indicated the adequacy of selected statistical model to fit well as depicted in [Figure 4]a,[Figure 4]b,[Figure 4]c,[Figure 4]d,[Figure 4]e,[Figure 4]f. Levels of factors significantly influenced the responses of Y1, Y2, and Y3 differently.
|Table 3: Formulation variables in Box-Behnken design used to prepare 15 formulations|
Click here to view
|Figure 3: (a-i) 3D response surface plots of Y1, Y2, and Y3 at different levels of X1, X2, and X3|
Click here to view
|Figure 4: (a-f) Diagnostic plots of adequacy of model derived for Y1, Y2, Y3 responses|
Click here to view
Thermodynamic stability studies of SNEDDS were resulted with phase separation, creaming, precipitation, and coalescence of oil droplets for 4, 5, and 8 formulation runs as demonstrated in [Table 1]. Isotropic systems of 4, 8, and 14 runs were turned to bright milky. Most of the SNEDDS runs were thermodynamically stable and homogeneous over a period.
Being characteristic property, transmittance affects the droplet size of stable emulsion. The percent limpidity was low in slightly turbid nanoemulsion of run 4 (74%) as shown in [Table 1] owing to higher surfactant (75 mg) and cosurfactant (45 mg) concentrations. Whereas 98% limpidity response was shown by SNEDDS of run 15. Limpidity of nanoemulsion with uniformly distributed nanodroplets was as close to 100%. Quality characteristics of SNEDDS were obtained by BBD through polynomial equation in relation to response Y1 (% limpidity) and independent variables. The values of factors were substituted in equation (1), to obtain actual values of responses as:
With no time or in less than couple of minutes, the preconcentrates were emulsified on dilution with water at mild/gentle agitation. Above all, run 3 formulation was emulsified rapidly and produced a very clear and homogeneous nanoemulsion within 67 s with due concentrations of carriers [Table 1]. Whereas, run 14 was emulsified in 112 s owing to coalescence of concentrated lipid vehicle. Polynomial equation representing the response Y2 as SET and independent variables in terms of actual values was:
In vitro dissolution
Dissolution profiles of 15 formulations are displayed in [Figure 5]a,[Figure 5]b,[Figure 5]c. More than 50% of QP was released from SNEDDS from first 5 min of study. In this study, T15% was taken as a response variable (Y3) to optimize the dissolution profile of QP-loaded SNEDDS. T15% was observed as 77% in run 14 (minimum) and 95% in run 3 (maximum) as shown in [Table 1]. Entire dialysis bag contents were emptied within 30 min of the study. Factors such as % limpidity and SET had profound effect on drug release profiles and thus polynomial equation of Y3, a dependent variable was become:
|Figure 5: (a-c): Drug release profiles of quetiapine self-nanoemulsified drug delivery systems|
Click here to view
Identification of optimized formulation
As shown in [Table 3], the constraints applied for numerical optimization technique in BBD were to minimize SET, to maximize both percent limpidity and release of drug after 15 min. Actual values of optimal factors for olive oil, span 80, and PEG 400 were found as 20, 55.07, and 34.78 mg, respectively, with experimental responses of limpidity, SET, and T15 as 94%, 69 s, and 93.4%.
Zeta potential and droplet size analysis
Mean droplet size of optimized nanodispersion was found to be 89.68 nm, electrokinetic potential was −27.2 mV, and PDI was <1 and thus indicated the formation of stable nanodispersion of QP.
| Discussion|| |
Recent times, natural edible oils have exploited their limit of use over stability, owing to their sound safety profiles in terms of digestion and absorption. Being BCS Class II moiety, QP was more soluble in olive oil (3.607 mg/ml) owing to its long-chain fatty acid composition and thus facilitates lymphatic absorption. SNEDDs containing nonionic span 80 and PEG 400 are capable of resisting the pH changes during absorption process, reduce interfacial fluidity, and also free energy. With due higher emulsification efficiencies and limited number of flask inversions, selected nonionic amphiphiles enhance the dispersibility of SNEDDS, thereby increase QP absorption by utilizing aqueous pathways for permeation across the intestinal epithelium.
Characteristically, SNEDDS undergo several mesomorphic transformations which in turn led to loss of solvent capacity, narrow down of nanoemulsification zone, and precipitation of drug. However, addition of moderate amounts of PEG 400 was successfully retained nanoemulsification zone in the ternary phase diagram. Beyond the colored region, lipid vehicle concentration was high and led to heterogeneous micro/macrodispersions.
Thermodynamic stability and centrifugation had little or no effect on mesomorphic transformations of SNEDDS as they were not evident any phase separation, creaming, and coalescence. SNEDDS of runs 4, 5, and 8 stored at −21°C were slightly shifted to microemulsion region due to mesomorphic conversions and led coalescence as evidenced with cloudy/slight turbidity. However, interfacial tension in SNEDDS was sufficiently low, interfacial energy become comparable or even lower than its entropy and thereby free energy of entire nanodispersion became either zero or negative for thermodynamic stability of QP-loaded SNEDDS.
Limpidity of SNEDDS was critically affected with interfacial fluidity between olive oil and water phase. As shown in [Figure 3]a, the effect of Y1 at middle level of X3 and at low levels of X1 at 20 mg, limpidity was increased from 85% to 97% and X2 at 55 mg; it was further decreased from 95% to 85%. Proportionate dynamic viscosity of span 80 with its concentration in SNEDDS was also a major reason for transmittance decrease. Statistical effect on limpidity was observed to be decreased from 98% to 87% at low levels of olive oil (20 mg) and PEG 400 (33 mg) as shown in [Figure 3]b, with due contribution of cosurfactant, a polar moiety was led to faster dispersion and firm binding with increased interfacial fluidity in SNEDDS. On the other hand, Y1 was analyzed as 97% at low levels of X3 (55 mg) and X2 (33 mg) from RS plot as shown [Figure 3]c. As RS plots depicted in [Figure 3]a,[Figure 3]b,[Figure 3]c and analyzed, low levels of both span 80 (X2) and PEG 400 (X3) and intermediate level of olive oil (X1) are required to produce optimized SNEDDS. It was also clearly evident with intense dark bluish-green area of 3D plots.
The influence of X1 and X2 and their interaction on SET (Y2) at middle level of X3 are shown in [Figure 3]d. At low levels of X2 (span 80), Y2 was decreased from 100 to 72 s when X1 increased from 20 to 35 mg. It was therefore attributed that the spontaneous dispersion of surfactant and thus binds the emulsion droplets strongly, thereby reduction in interfacial free energy. QP-loaded SNEDDS resulted with certain mesomorphic changes in preconcentrates like disruption of liquid crystalline lamella of olive oil while it was diluted with water.,, It was also noted that SET was decreased with increase of X1, where versatile fatty acid composition of olive oil was typical. The same was portrayed in RS plot [Figure 3]e that SET was decreased with increase of olive oil and decreased at low levels of PEG 400. Effect of Y2 with respect to X2 and X3 at middle levels of X1 resulted with decreased Y2 with increased X3 as displayed in [Figure 3]f. To minimize SET, low levels of olive oil and span 80 and high levels of PEG 400 were required in optimization of stable SNEDDS of QP.
Variables form RS plot [Figure 3]g for in vitro dissolution (Y3) between X1 and X2 at intermediate levels of X3 were resulted with decreased T15% on increase of span 80 (X2). This outcome was in agreement with SET as emulsification was delayed due to viscous crystalline gel formation on increased span 80. As hypothesized similarly in limpidity response, olive oil led interfacial fluidity decreased the drug release. On the other hand, fluidity led voids in amphiphile monomers facilitated emulsification in lesser SET. As per RS analysis, increased trend in T15% was observed between intermediary levels of X1 and at low levels of X1 and X3 [Figure 3]h. Similarly, Y3 between X2 and X3 at predetermined intermediate levels of X1 divulged with increased in X2 and vice versa, with an increase in X3 [Figure 3]i. To optimize the QP-loaded SNEDDS with maximized T15%, high levels of olive oil (X1) and PEG 400 (X3), while intermediate levels of span 80 (X2) were considered.
Model adequacy plots of responses, as provided in [Table 4], all regression coefficients of responses were in good agreement with r2 and adjusted r2 that indicated the best fit to the response for limpidity, SET and T15%. Model equation of ANOVA with F values, probability >F (P value), and nonsignificant lack of fit of all the dependent variables exposed that the quadratic model was statistically significant. Further degree of precision and reliability of performed experiments were supplemented with squat value of coefficient of variation (%CV). Values of adequate precision and predicted residual error sum of squares of all responses employed in design were clearly explained that how the adapted model was fitted with each point of BBD. As predicted and experimental responses lie nearer to and on straight line explained that derived model was able to envisage linear relationship between formulation variables and responses. Data were randomly dispersed within limits of ± 3 and thus confirmed that the selected statistical model was adequately fit for the experimental design of QP-loaded SNEDDS as shown in [Figure 4]a,[Figure 4]b,[Figure 4]c,[Figure 4]d,[Figure 4]e,[Figure 4]f. Operability in actual preparation/process the optimal conditions were considered as X1 (olive oil) = 20 mg, X2 (span 80) = 55 mg, and X3 (PEG 400) = 34.5 mg with respective regression of 0.99, 0.99, and 0.70. Mean of triplicate BBD experimental values were resulted with 98% of transmittance, 66 s of SET, and 95.2% of T15.
|Table 4: Regression coefficients of actual values and model adequacies for responses|
Click here to view
As shown in [Table 3], the constraints applied for numerical optimization technique in BBD were to minimize SET, to maximize both percent limpidity and release of drug after 15 min. Regression equation for the preparation of QP SNEDDS were given in the coded form was found to be X1 = 0.99, X2 = 0.99, and X3 = 0.70. Operability in actual preparation/process the optimal conditions were considered as X1 (olive oil) = 20 mg, X2 (span 80) = 55 mg, and X3 (PEG 400) = 34.5 mg with respective regression of 0.99, 0.99, and 0.70. Mean of triplicate BBD experimental values were resulted in 98% of transmittance, 66 s of SET, and 95.2% of T15. Actual values of optimal factors for olive oil, span 80, and PEG 400 were found as 20, 55.07, and 34.78 mg, respectively, with experimental responses of limpidity, SET, and T15 as 94%, 69 s, and 93.4%. As a result, BBD was considered to be an accurate, robust, and significant tool in predicting the responses of QP-loaded liquid SNEDDS.
Mean droplet size of optimized nanodispersion was found to be 89.68 nm, electrokinetic potential was 27.2 mV and PDI was <1 and thus indicated the formation of stable nanodispersion of QP. Outcomes of study on electrokinetic parameters of interfaces of optimized SNEDDS were the direct results of thermodynamic stability of that isotropic system. Data on droplet size analysis and PDI indicated the uniform distribution of globules in self-nanodispersions of QP and were assisted by span 80 and PEG 400 with reduced interfacial interactions. As zeta potential was negative, QP-loaded SNEDDS follow intestinal lymphatic absorption, since intestinal cells carry characteristic negative charges due to luminal/mucosal fluidity.
| Conclusion|| |
BBD was effectively employed to optimize QP-loaded SNEDDS composed of olive oil (X1), span 80 (X2), and PEG 400 (X3). These independent variables affected the limpidity, SET, and T15% of SNEDDS through linear, quadratic, and interaction effects. Resulted data from BBD were utilized to design the optimized SNEDDS. These optimized SNEDDS were thermodynamically stable and chemically intact over a period. Overall, BBD was successful and most suitable in optimization of particulate emulsified systems such as QP-loaded SNEDDS. Further,in vivo studies are required to scale-up the process of SNEDDS.
The authors are grateful to M/s. Aurobindo Pharma Ltd., Hyderabad, for gratis of QP sample and the management of Krishna Teja Pharmacy College, Tirupati, India, for rendering generous support to carry out the research work.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Shah B, Khunt D, Misra M, Padh H. Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route. Int J Biol Macromol 2016;89:206-18.
Garcia-Garcia E, Andrieux K, Gil S, Couvreur P. Colloidal carriers and blood-brain barrier (BBB) translocation: A way to deliver drugs to the brain? Int J Pharm 2005;298:274-92.
Al Jurdi RK, Dixit LA, Sajatovic M. Role of extended release quetiapine in the management of bipolar disorders. Neuropsychiatr Dis Treat 2010;6:29-35.
Ogawa N, Kaga M, Endo T, Nagase H, Furuishi T, Yamamoto H, et al.
Quetiapine free base complexed with cyclodextrins to improve solubility for parenteral use. Chem Pharm Bull (Tokyo) 2013;61:809-15.
Ali AM, Al-Remawi MM. Freeze dried quetiapine-nicotinamide binary solid dispersions: A new strategy for improving physicochemical properties and ex vivo
diffusion. J Pharm (Cairo) 2016;2016:2126056.
Li JC, Zhang WJ, Zhu JX, Zhu N, Zhang HM, Wang X, et al.
Preparation and brain delivery of nasal solid lipid nanoparticles of quetiapine fumarate in situ
gel in rat model of schizophrenia. Int J Clin Exp Med 2015;8:17590-600.
Narala A, Veerabrahma K. Preparation, characterization and evaluation of quetiapine fumarate solid lipid nanoparticles to improve the oral bioavailability. J Pharm (Cairo) 2013;2013:265741.
Yasir M, Gaur PK, Puri D, Shekar P, Kumar SS. Solid lipid nanoparticles approach for lymphatic targeting through intraduodenal delivery of quetiapine fumarate. Curr Drug Deliv 2017;14:1-11.
Aboti P, Shah P, Patel D, Dalwadi S. Quetiapine fumarate loaded solid lipid nanoparticles for improved oral bioavailability. Drug Deliv Lette 2014;4:170-84.
Carreño F, Paese K, Silva CM, Guterres SS, Dalla Costa T. Pharmacokinetic investigation of quetiapine transport across blood-brain barrier mediated by lipid core nanocapsules using brain microdialysis in rats. Mol Pharm 2016;13:1289-97.
Boche M, Pokharkar V. Quetiapine nanoemulsion for intranasal drug delivery: Evaluation of brain-targeting efficiency. AAPS PharmSciTech 2017;18:686-96.
El-Zahaby SA, AbouGhaly MH, Abdelbary GA, El-Gazayerly ON. Zero-order release and bioavailability enhancement of poorly water soluble vinpocetine from self-nanoemulsifying osmotic pump tablet. Pharm Dev Technol 2017;8:1-11.
Alshahrani SM, Alshetaili AS, Alalaiwe A, Alsulays BB, Anwer MK, Al-Shdefat R, et al.
Anticancer efficacy of self-nanoemulsifying drug delivery system of sunitinib malate. AAPS PharmSciTech 2018;19:123-33.
Patel J, Kevin G, Patel A, Raval M, Sheth N. Design and development of a self-nanoemulsifying drug delivery system for telmisartan for oral drug delivery. Int J Pharm Investig 2011;1:112-8.
Pavani S, Madusudhan Rao Y, Shravan Kumar Y. Use of box-behnken experimental design for optimization of process variables in iontophoretic delivery of repaglinide. J Young Pharm 2016;8:350-5.
Xi J, Chang Q, Chan CK, Meng ZY, Wang GN, Sun JB, et al.
Formulation development and bioavailability evaluation of a self-nanoemulsified drug delivery system of oleanolic acid. AAPS PharmSciTech 2009;10:172-82.
Singh B, Bhatowa R, Tripathi CB, Kapil R. Developing micro-/nanoparticulate drug delivery systems using “design of experiments”. Int J Pharm Investig 2011;1:75-87.
Elnaggar YS, El-Massik MA, Abdallah OY. Self-nanoemulsifying drug delivery systems of tamoxifen citrate: Design and optimization. Int J Pharm 2009;380:133-41.
Kalhapure RS, Akamanchi KG. Oleic acid based heterolipid synthesis, characterization and application in self-microemulsifying drug delivery system. Int J Pharm 2012;425:9-18.
Khan AW, Kotta S, Ansari SH, Sharma RK, Ali J. Self-nanoemulsifying drug delivery system (SNEDDS) of the poorly water-soluble grapefruit flavonoid naringenin: Design, characterization,in vitro
and in vivo
evaluation. Drug Deliv 2015;22:552-61.
Verma S, Singh SK, Verma PR, Ahsan MN. Formulation by design of felodipine loaded liquid and solid self nanoemulsifying drug delivery systems using Box-Behnken design. Drug Dev Ind Pharm 2014;40:1358-70.
Zidan AS, Sammour OA, Hammad MA, Megrab NA, Habib MJ, Khan MA, et al.
Quality by design: Understanding the formulation variables of a cyclosporine A self-nanoemulsified drug delivery systems by Box-Behnken design and desirability function. Int J Pharm 2007;332:55-63.
Raju YP, Hyndavi N, Chowdary VH, Nair RS, Basha DJ, Tejeswari N, et al. In vitro
assessment of non-irritant microemulsified voriconazole hydrogel system. Artif Cells Nanomed Biotechnol 2017;45:1539-47.
Krugliak P, Hollander D, Ma TY, Tran D, Dadufalza VD, Katz KD, et al.
Mechanisms of polyethylene glycol 400 permeability of perfused rat intestine. Gastroenterology 1989;97:1164-70.
Chowdary VH, Prasanna Raju Y, Rao MV, Sundaresan CR. Insights of microemulsions – A thermodynamic comprehension. Jordan J Pharm Sci 2017;10:23-40.
Iranloye TA, Pilpel N, Groves MJ. Some factors affecting the droplet size and charge of dilute oil-in-water emulsions prepared by self-emulsification. J Disper Sci Technol 1983;4:109-21.
Mohsin K, Shahba AA, Alanazi FK. Lipid-based self-emulsifying formulations for poorly water-soluble drugs – An excellent opportunity. Indian J Pharm Educ Res 2012;2:88-96.
Constantinides PP, Scalart JP, Lancaster C, Marcello J, Marks G, Ellens H, et al.
Formulation and intestinal absorption enhancement evaluation of water-in-oil microemulsions incorporating medium-chain glycerides. Pharm Res 1994;11:1385-90.
Shanmugaprakash M, Kirthika J, Ragupathy J, Nilanee K, Manickam A. Statistical based media optimization and production of naringinase using Aspergillus brasiliensis
1344. Int J Biol Macromol 2014;64:443-52.
Gershanik T, Benita S. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm 2000;50:179-88.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5]
[Table 1], [Table 2], [Table 3], [Table 4]